CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020		98,035,829
Beginning balance at Dec. 31, 2020	$ 25,289,114	$ 98,036	$ 161,541,448	$ (136,350,370)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,147,268)			(2,147,268)
Stock-based compensation	394,870		394,870
Stock issued for vested restricted stock awards (in shares)		1,467,465
Stock issued for vested restricted stock awards	0	$ 1,467	(1,467)
Shares withheld for taxes on vested restricted stock	(161,244)		(161,244)
Proceeds from exercise of options	1,569		1,569
Sale of common stock, net (in shares)		19,015,151
Sale of common stock, net	13,137,500	$ 19,016	13,118,484
Ending balance (in shares) at Mar. 31, 2021		118,518,445
Ending balance at Mar. 31, 2021	36,514,541	$ 118,519	174,893,660	(138,497,638)
Beginning balance (in shares) at Dec. 31, 2020		98,035,829
Beginning balance at Dec. 31, 2020	25,289,114	$ 98,036	161,541,448	(136,350,370)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(6,359,663)
Unrealized gain (loss) on debt securities	0
Ending balance (in shares) at Sep. 30, 2021		118,747,447
Ending balance at Sep. 30, 2021	33,369,062	$ 118,748	175,960,347	(142,710,033)
Beginning balance (in shares) at Mar. 31, 2021		118,518,445
Beginning balance at Mar. 31, 2021	36,514,541	$ 118,519	174,893,660	(138,497,638)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,382,127)			(2,382,127)
Stock-based compensation	557,602		557,602
Ending balance (in shares) at Jun. 30, 2021		118,518,445
Ending balance at Jun. 30, 2021	34,690,016	$ 118,519	175,451,262	(140,879,765)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,830,268)			(1,830,268)
Unrealized gain (loss) on debt securities	0
Stock-based compensation	613,544		613,544
Stock issued for vested restricted stock awards (in shares)		229,002
Stock issued for vested restricted stock awards	0	$ 229	(229)
Shares withheld for taxes on vested restricted stock	(110,805)		(110,805)
Stock warrants issued for referral agreement	6,575		6,575
Ending balance (in shares) at Sep. 30, 2021		118,747,447
Ending balance at Sep. 30, 2021	33,369,062	$ 118,748	175,960,347	(142,710,033)
Beginning balance (in shares) at Dec. 31, 2021		118,747,447
Beginning balance at Dec. 31, 2021	32,807,995	$ 118,748	176,586,529	(143,951,019)	$ 53,737
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,089,263)			(2,089,263)
Unrealized gain (loss) on debt securities	(98,156)				(98,156)
Stock-based compensation	671,158		671,158
Stock issued for vested restricted stock awards (in shares)		1,059,755
Stock issued for vested restricted stock awards	0	$ 1,060	(1,060)
Shares withheld for taxes on vested restricted stock	(128,520)		(128,520)
Stock warrants issued for referral agreement	12,483		12,483
Ending balance (in shares) at Mar. 31, 2022		119,807,202
Ending balance at Mar. 31, 2022	31,175,697	$ 119,808	177,140,590	(146,040,282)	(44,419)
Beginning balance (in shares) at Dec. 31, 2021		118,747,447
Beginning balance at Dec. 31, 2021	32,807,995	$ 118,748	176,586,529	(143,951,019)	53,737
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(9,129,756)
Unrealized gain (loss) on debt securities	(186,239)
Ending balance (in shares) at Sep. 30, 2022		120,137,124
Ending balance at Sep. 30, 2022	25,214,581	$ 120,138	178,307,716	(153,080,771)	(132,502)
Beginning balance (in shares) at Mar. 31, 2022		119,807,202
Beginning balance at Mar. 31, 2022	31,175,697	$ 119,808	177,140,590	(146,040,282)	(44,419)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,229,927)			(3,229,927)
Unrealized gain (loss) on debt securities	(124,253)				(124,253)
Stock-based compensation	684,376		684,376
Stock issued for vested restricted stock awards (in shares)		66,666
Stock issued for vested restricted stock awards	0	$ 66	(66)
Stock warrants issued for referral agreement	462		462
Ending balance (in shares) at Jun. 30, 2022		119,873,868
Ending balance at Jun. 30, 2022	28,506,355	$ 119,874	177,825,362	(149,270,209)	(168,672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,810,562)			(3,810,562)
Unrealized gain (loss) on debt securities	36,170				36,170
Stock-based compensation	535,458		535,458
Stock issued for vested restricted stock awards (in shares)		263,256
Stock issued for vested restricted stock awards	0	$ 264	(264)
Shares withheld for taxes on vested restricted stock	(68,372)		(68,372)
Stock warrants issued for referral agreement	15,532		15,532
Ending balance (in shares) at Sep. 30, 2022		120,137,124
Ending balance at Sep. 30, 2022	$ 25,214,581	$ 120,138	$ 178,307,716	$ (153,080,771)	$ (132,502)